Search

Your search keyword '"Romano, Alessandra"' showing total 1,101 results

Search Constraints

Start Over You searched for: Author "Romano, Alessandra" Remove constraint Author: "Romano, Alessandra"
1,101 results on '"Romano, Alessandra"'

Search Results

1. Comprehensive analysis of clinical outcomes, infectious complications and microbiological data in newly diagnosed multiple myeloma patients: a retrospective observational study of 92 subjects

3. 'Una Faccia, Una Razza': Similarities, Differences, and Parallels in Adult Education Policy Development in Greece and Italy

4. Innovation as Socially Shared Practice: The Contribution of the Teaching and Learning Center

5. Our Global Learning Community in the Clouds: Adaptive Ecological Elements and Practices

6. Does It Really Take a Village to Raise a Child? Reflections on the Need for Collective Responsibility in Inclusive Education

7. Psychological distress and suicidal ideation in Sicilian Medical Students: The SMS-ME project

8. Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022

9. A Methodological Framework to Cultivate Transformative Learning in Faculty Development

10. Seismic Base Isolation of a Strategic Historic Masonry Building

11. Innovation as socially shared practice: the contribution of the Teaching and Learning Center

13. Chapter Professional Development Tutoring: Comparing Italian and International Models

18. MOLNUPIRAVIR COMPARED TO NIRMATRELVIR/RITONAVIR FOR COVID-19 IN HIGH-RISK PATIENTS WITH HAEMATOLOGICAL MALIGNANCY IN EUROPE. A MATCHED-PAIRED ANALYSIS FROM THE EPICOVIDEHA REGISTRY

19. Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022

20. CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment

21. In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection

23. IgG-k/IgG-λ Para-Osseous Plasmacytoma Relapsed as Soft-Tissue Plasmacytoma with IgA-k Immunophenotype: A Case Report and Review of the Literature on Related Biochemical Aspects.

25. A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study

26. How Do Attitudes and Self-Efficacy Predict Teachers’ Intentions to Use Inclusive Practices? A Cross-National Comparison Between Canada, Germany, Greece, Italy, and Switzerland

27. Baseline IgM Amounts Can Identify Patients with Poor Outcomes: Results from a Real-Life Single-Center Study on Classical Hodgkin Lymphoma

31. Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022

33. Effectiveness, safety, and tolerability of delayed dexamethasone, rituximab, and cyclophosphamide as first-line treatment in patients with Waldenström macroglobulinemia: data from the Sicilian Myeloma Network.

34. Enhanced Antitumor Activity by the Combination of Dasatinib and Selinexor in Chronic Myeloid Leukemia.

35. Belantamab Mafodotin and Relapsed/Refractory Multiple Myeloma: This Is Not Game Over.

37. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

39. High-dose chemotherapy and autologous stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin Lymphoma in the era of PET-adapted strategies

40. Patients' Perception of Usability and Utility of a Digital Health Tool for Electronic Patient-Reported Outcomes Monitoring in Real-Life Hematology Practice: Evidence from the Gimema-Alliance Platform

41. Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological Cancers

43. Multiple Myeloma in 2023 Ways: From Trials to Real Life

44. Engagement of Mesenchymal Stromal Cells in the Remodeling of Bone Marrow Microenvironment in Hematological Cancers

45. Measuring collective efficacy for inclusion in a global context.

46. Potential clinical impact of T-cell lymphocyte kinetics monitoring in patients with B cell precursors acute lymphoblastic leukemia treated with blinatumomab: a single-center experience

47. Breakthrough infection after SARS-CoV-2 vaccines in patients with hemoglobinopathies and blood-transfusion management: a single Center experience

48. IBCL-057 Incidence and Features of SARS-CoV-2 Breakthrough Infection in the Hematological Conditions After Tixagevimab-Cilgavimab Prophylaxis

49. Efficacy and safety of tixagevimab‐cilgavimab versus SARS‐CoV‐2 breakthrough infection in the hematological conditions

50. POSTER: IBCL-057 Incidence and Features of SARS-CoV-2 Breakthrough Infection in the Hematological Conditions After Tixagevimab-Cilgavimab Prophylaxis

Catalog

Books, media, physical & digital resources